从SPARCL研究看脑卒中的他汀类药物治疗重要性

被引：11

作者：

张茁

机构：

[1] 首都医科大学附属北京安贞医院神经内科

来源：

中华老年心脑血管病杂志 | 2012年 / 14卷 / 05期

关键词：

卒中; 脑缺血发作,短暂性; 动脉粥样硬化; 胆固醇,LDL; 抗胆固醇血症药;

D O I：

暂无

中图分类号：

R743.3 [急性脑血管疾病（中风）];

学科分类号：

1002 ;

摘要：

<正>他汀类药物在脑卒中患者中的应用,既往多是在冠心病人群中进行的一级预防研究。虽然,这些研究一致证实,他汀类药物用于脑卒中一级预防能降低脑卒中风险,但对于已经罹患缺血性脑卒中的患者,他汀类药物作用如何,一直不得而知。心脏保护研究(HPS)的脑卒中和(或)短暂性脑缺血发作(TIA)亚组分析,同样未能支持脑卒中患者应使用他

引用

页码：451 / 453

页数：3

共 11 条

[1]

Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels(SPARCL) trial by stroke subtypes. Amarenco P,Benavente O,Goldstein LB, et al. Stroke . 2009

[2]

Effects of intense low density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack:the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Amarenco P,Goldstein LB,Szarek M, et al. Stroke . 2007

[3]

Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis. A Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. H. Sillesen,P. Amarenco,M.G. Hennerici. Stroke . 2008

[4]

Effects of intensivemedical therapy on microemboli and cardiovascular risk inasymptomatic carotid stenosis. Spence JD,Coates V,Li H,et al. Archives of Neurology . 2010

[5]

Treating arteries instead of risk factors:a paradigm change in management of atherosclerosis. Spence JD,Hackam DG. Stroke . 2010

[6]

High-dose atorvastatin after stroke or transient ischemic attack. Amarenco P,Bogousslavsky J,Callahan A,et al. The New England Journal of Medicine . 2006

[7]

The North Dublin Population Stroke Study. Chroinin DN,Callaly EL,Duggan J,et al. Stroke . 2011

[8] 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010 [J].

中华神经科杂志, 2010, (02) :154-160

[9]

Treating Arteries Instead of Risk Factors: A Paradigm Change in Management of Atherosclerosis[J] . J. David Spence,Daniel G. Hackam. &nbspStroke . 2010 (6)

[10]

Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke or Transient Ischemic Attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial[J] . Pierre Amarenco,Larry B. Goldstein,Michael Szarek,Henrik Sillesen,Amy E. Rudolph,Alfred Callahan,Michael Hennerici,Lisa Simunovic,Justin A. Zivin,K Michael A. Welch. &nbspStroke . 2007 (12)

← 1 2 →